ResearcherUniversity Hospital Schleswig-HolsteinNo recent work listed
Dirk Rades
Matched on ORCID iD 0009-0008-2046-4968; OpenAlex author ID A5057206849. Sources: OpenAlex.
Their work
- Papers
- 6 (first author 0, last author 1)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 22
2014: 1 paper · 2015: 2 papers · 2016: none · 2017: 1 paper · 2018: none · 2019: none · 2020: none · 2021: 1 paper · 2022: 1 paper
Papers 6
- Concepts and Outcomes of Perioperative Therapy in Stage IA-III Pancreatic Cancer-A Cross-Validation of the National Cancer Database (NCDB) and the German Cance… Co-author DOI 10.3390/cancers14040868↗
- Postoperative Outcomes of Tangential versus Segmental Resection and End-to-end Reconstruction of the Superior Mesenterico-Portal Vein During Pancreatoduodenect… Co-author DOI 10.21873/anticanres.15329↗
- The Role of Fibroblasts in Pancreatic Cancer: Extracellular Matrix Versus Paracrine Factors. Co-author DOI 10.1016/j.tranon.2017.04.009↗
- Dasatinib blocks transcriptional and promigratory responses to transforming growth factor-beta in pancreatic adenocarcinoma cells through inhibition of Smad si… Co-author DOI 10.1186/s12943-015-0468-0↗
- Predicting Survival After Irradiation of Metastases from Pancreatic Cancer. Last author PMID 26124362↗
- Metastatic spinal cord compression from pancreatic cancer. Co-author PMID 24982394↗
Closest collaborators
The 22 strongest of 22 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Louisa Bolm · 4 shared papers, 2015–2022 · strength 0.36
- Paper Concepts and Outcomes of Perioperative Therapy in Stage IA-III Pancreatic Cancer-A Cross-Validation of the National Can… DOI 10.3390/cancers14040868↗
- Paper Postoperative Outcomes of Tangential versus Segmental Resection and End-to-end Reconstruction of the Superior Mesenteri… DOI 10.21873/anticanres.15329↗
- Paper The Role of Fibroblasts in Pancreatic Cancer: Extracellular Matrix Versus Paracrine Factors. DOI 10.1016/j.tranon.2017.04.009↗
- Ulrich Friedrich Wellner · 4 shared papers, 2015–2022 · strength 0.36
- Paper Concepts and Outcomes of Perioperative Therapy in Stage IA-III Pancreatic Cancer-A Cross-Validation of the National Can… DOI 10.3390/cancers14040868↗
- Paper Postoperative Outcomes of Tangential versus Segmental Resection and End-to-end Reconstruction of the Superior Mesenteri… DOI 10.21873/anticanres.15329↗
- Paper The Role of Fibroblasts in Pancreatic Cancer: Extracellular Matrix Versus Paracrine Factors. DOI 10.1016/j.tranon.2017.04.009↗
- Tobias Keck · 3 shared papers, 2017–2022 · strength 0.30
- Paper Concepts and Outcomes of Perioperative Therapy in Stage IA-III Pancreatic Cancer-A Cross-Validation of the National Can… DOI 10.3390/cancers14040868↗
- Paper Postoperative Outcomes of Tangential versus Segmental Resection and End-to-end Reconstruction of the Superior Mesenteri… DOI 10.21873/anticanres.15329↗
- Paper The Role of Fibroblasts in Pancreatic Cancer: Extracellular Matrix Versus Paracrine Factors. DOI 10.1016/j.tranon.2017.04.009↗
- Ekaterina Petrova · 2 shared papers, 2021–2022 · strength 0.23
- Paper Concepts and Outcomes of Perioperative Therapy in Stage IA-III Pancreatic Cancer-A Cross-Validation of the National Can… DOI 10.3390/cancers14040868↗
- Paper Postoperative Outcomes of Tangential versus Segmental Resection and End-to-end Reconstruction of the Superior Mesenteri… DOI 10.21873/anticanres.15329↗
- Hryhoriy V. Lapshyn · 2 shared papers, 2021–2022 · strength 0.23
- Paper Concepts and Outcomes of Perioperative Therapy in Stage IA-III Pancreatic Cancer-A Cross-Validation of the National Can… DOI 10.3390/cancers14040868↗
- Paper Postoperative Outcomes of Tangential versus Segmental Resection and End-to-end Reconstruction of the Superior Mesenteri… DOI 10.21873/anticanres.15329↗
- Rüdiger Braun · 2 shared papers, 2021–2022 · strength 0.23
- Paper Concepts and Outcomes of Perioperative Therapy in Stage IA-III Pancreatic Cancer-A Cross-Validation of the National Can… DOI 10.3390/cancers14040868↗
- Paper Postoperative Outcomes of Tangential versus Segmental Resection and End-to-end Reconstruction of the Superior Mesenteri… DOI 10.21873/anticanres.15329↗
- Kim C. Honselmann · 2 shared papers, 2021–2022 · strength 0.23
- Paper Concepts and Outcomes of Perioperative Therapy in Stage IA-III Pancreatic Cancer-A Cross-Validation of the National Can… DOI 10.3390/cancers14040868↗
- Paper Postoperative Outcomes of Tangential versus Segmental Resection and End-to-end Reconstruction of the Superior Mesenteri… DOI 10.21873/anticanres.15329↗
- Natalie Petruch · 2 shared papers, 2021–2022 · strength 0.23
- Paper Concepts and Outcomes of Perioperative Therapy in Stage IA-III Pancreatic Cancer-A Cross-Validation of the National Can… DOI 10.3390/cancers14040868↗
- Paper Postoperative Outcomes of Tangential versus Segmental Resection and End-to-end Reconstruction of the Superior Mesenteri… DOI 10.21873/anticanres.15329↗
- Tobias Bartscht · 3 shared papers, 2014–2015 · strength 0.17
- Paper Metastatic spinal cord compression from pancreatic cancer. PMID 24982394↗
- Paper Predicting Survival After Irradiation of Metastases from Pancreatic Cancer. PMID 26124362↗
- Paper Dasatinib blocks transcriptional and promigratory responses to transforming growth factor-beta in pancreatic adenocarci… DOI 10.1186/s12943-015-0468-0↗
- Carlos Fernández-del Castillo · 1 shared paper, 2022 · strength 0.11
- Taisuke Baba · 1 shared paper, 2022 · strength 0.11
- Alexander V. Kirichenko · 1 shared paper, 2022 · strength 0.11
- Hiroki Sato · 1 shared paper, 2022 · strength 0.11
- Rodney E. Wegner · 1 shared paper, 2022 · strength 0.11
- Jon Michael Harrison · 1 shared paper, 2022 · strength 0.11
- Dirk Bausch · 1 shared paper, 2021 · strength 0.11
- Steffen Deichmann · 1 shared paper, 2021 · strength 0.11
- Birte Kulemann · 1 shared paper, 2021 · strength 0.11
- Jens Hoeppner · 1 shared paper, 2021 · strength 0.11
- Uwe A. Wittel · 1 shared paper, 2017 · strength 0.07
- Hendrik Lehnert · 1 shared paper, 2015 · strength 0.05
- Hendrik Ungefroren · 1 shared paper, 2015 · strength 0.05
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.